Process for differential diagnosis of alzheimer's dementia and device therefor
CA 2445367 A1 · Owner: Jackowski, George · Inventors: Jackowski, George; Takahashi, Miyoko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
A method for diagnosing Alzheimer's disease(AD) is disclosed. The method involves directly detecting the presence of a biochemical marker specifically , human glutamine synthetase in bodily fluid, preferably blood or a blood product. The detection is by an immunoassay incorporating an antibody specific to human glutamine synthetase. In addition a method for distinguishing , between AD and non-AD dementia is disclosed.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 24, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended April 24, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 24, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.